Modern Health Observation

U.S. health representatives, the Reuters news agency reported that according to tests performed in the United States with the H1N1 influenza vaccine from Sanofi-Pasteur SA and CSL Ltd., only one dose is needed to protect people of the disease.

“I am pleased to tell you that the initial results of tests sponsored by the NIH (National Institutes of Health) corroborate and reinforce the findings of the companies,” said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.

In a press conference, Fauci said that the immune response was swift and that people seemed to be protected 8-10 days after being vaccinated.

Secretary of Health and Human Services, Kathleen Sebelius, said in the same conference that “it is more likely than Americans to get vaccinated against influenza A/H1N1, are immunized and protected against the virus more quickly than thought” .

Fauci said that the evidence also showed very few side effects so far and all were minor.

CSL reported this week that tests showed that a single dose of vaccine is sufficient to achieve immunity. Novartis AG and China’s Sinovac Biotech Ltd. have also stated that a sufficient dose of the vaccine to protect people. The Government of China recently approved product manufactured by Sinovac.